CDK4 抗体 (AA 253-303)
Quick Overview for CDK4 抗体 (AA 253-303) (ABIN7455013)
抗原
See all CDK4 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 253-303
-
原理
- Rabbit anti-CDK4 Antibody, Affinity Purified
-
纯化方法
- Affinity Purified
-
免疫原
- Between AA 253 and 303
-
亚型
- IgG
-
-
-
-
应用备注
-
IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
限制
- 仅限研究用
-
-
-
浓度
- 1000 μg/mL
-
缓冲液
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- CDK4 (Cyclin-Dependent Kinase 4 (CDK4))
-
别名
- CDK4
-
背景
- Background: Cyclin dependent kinase 4 (CDK4) is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of CDK4 is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in the CDK4 gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers [taken from NCBI Entrez Gene (Gene ID: 1019)].
-
基因ID
- 1019
-
NCBI登录号
- NP_000066
-
UniProt
- P11802
-
途径
- Cell Division Cycle, Mitotic G1-G1/S Phases, Regulation of Cell Size
抗原
-